22 Sep Mild to Moderate Alzheimer’s Disease Treated with Donepezil…Complete
Randomized, double-blind, placebo-controlled, fixed dose study of Lu AE58054 in patients with mild to moderate Alzheimer's disease treated with Donepezil.This is a 28 week study in which qualified participants will take the investigational medication or placebo ( a dummy capsule without an active ingredient )...